MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$524,747K
(225.04%↑ Y/Y)
Marketable securities
$494,235K
(151.23%↑ Y/Y)
Prepaid expenses and
other current assets
$5,212K
(32.12%↑ Y/Y)
Property and equipment,
gross
$729K
(-65.52%↓ Y/Y)
Total current assets
$1,024,194K
(182.84%↑ Y/Y)
Operating lease assets
$837K
(-32.93%↓ Y/Y)
Property and equipment,
net
$47K
(-78.83%↓ Y/Y)
Less accumulated
depreciation
$682K
(-63.95%↓ Y/Y)
Total assets
$1,025,078K
(181.67%↑ Y/Y)
Total liabilities and
stockholders' equity
$1,025,078K
(181.67%↑ Y/Y)
Total stockholders'
equity
$1,006,524K
(191.01%↑ Y/Y)
Total liabilities
$18,554K
(2.74%↑ Y/Y)
Accumulated deficit
-$517,688K
(-22.83%↓ Y/Y)
Additional paid-in capital
$1,523,941K
(98.53%↑ Y/Y)
Total current
liabilities
$16,411K
(4.86%↑ Y/Y)
Taxes payable,
non-current
$1,698K
(13.96%↑ Y/Y)
Operating lease
liabilities, non-current
$445K
(-51.58%↓ Y/Y)
Accumulated other
comprehensive loss
$260K
(193.19%↑ Y/Y)
Common stock, 0.0001
par value,...
$11K
(22.22%↑ Y/Y)
Accrued expenses and
other current...
$14,216K
(8.73%↑ Y/Y)
Accounts payable
$1,721K
(-19.88%↓ Y/Y)
Current portion of
operating lease...
$474K
(10.75%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (TERN)